DSGN
Design Therapeutics Inc

379
Mkt Cap
$418.11M
Volume
556,859.00
52W High
$7.93
52W Low
$2.60
PE Ratio
-6.18
DSGN Fundamentals
Price
$7.85
Prev Close
$7.34
Open
$8.07
50D MA
$6.55
Beta
1.56
Avg. Volume
189,456.00
EPS (Annual)
-$0.8763
P/B
2.09
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Design Therapeutics (NASDAQ:DSGN) Given New $6.00 Price Target at Royal Bank Of Canada
Royal Bank Of Canada lifted their target price on shares of Design Therapeutics from $5.00 to $6.00 and gave the company a "sector perform" rating in a research note on Thursday...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
Design Therapeutics (NASDAQ:DSGN - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.30) earnings per share for the quarter, beating the consensus...
MarketBeat·14d ago
News Placeholder
Biotech stocks jump as Makary outlines FDA vision, RBC comments
Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers. In his first major interview since taking office, Makary emphasized pragmatic reforms, faster drug approvals, and modernized use of real-world data across the agency.
investing.com·7mo ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock
Design Therapeutics, Inc. (NASDAQ:DSGN Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were...
Ticker Report·2y ago
News Placeholder
Design Therapeutics (DSGN, $3.9) RSI Indicator left the overbought zone on March 27, 2024
This is a signal that DSGN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Design Therapeutics (DSGN, $3.58) RSI Indicator left the overbought zone on March 26, 2024
This is a signal that DSGN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Equities Analysts Set Expectations for Design Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:DSGN)
Design Therapeutics, Inc. (NASDAQ:DSGN Free Report) Analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for shares of Design Therapeutics in a research report issued on...
Zolmax·2y ago
News Placeholder
Design Therapeutics (DSGN, $3.25) RSI Indicator left the overbought zone on March 21, 2024
This is a signal that DSGN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Rating of "Hold" from Brokerages
Design Therapeutics, Inc. (NASDAQ:DSGN Get Free Report) has been given a consensus recommendation of Hold by the seven research firms that are currently covering the company...
Ticker Report·2y ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Receives "Neutral" Rating from Wedbush
Design Therapeutics (NASDAQ:DSGN Get Free Report)s stock had its neutral rating reissued by Wedbush in a report issued on Wednesday, Benzinga reports. They presently have...
Ticker Report·2y ago

Latest DSGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.